Kestrel Therapeutics
Ashwin Gollerkeri currently serves as Chief Medical Officer at Kestrel Therapeutics since January 2025. Prior to this role, Ashwin was Senior Vice President and Head of Development at Kymera Therapeutics from January 2021 to December 2024. Ashwin's extensive experience in the biopharmaceutical industry includes significant positions such as Vice President of Clinical Sciences in Oncology at Array BioPharma Inc. and various roles at Pfizer, Novartis, and Bristol Myers Squibb, culminating in leadership positions at the Director level. Ashwin holds a Doctor of Medicine degree from the University of Kansas Medical Center and a Bachelor of Arts in Cell and Developmental Biology from Northwestern University.
This person is not in any teams